Canada Health advises the consumers not to use the unauthorized natural products of health Zimaxx, Actra-Rx, 4Everon, Vigor-25 and Nasutra since they adulterated pharmaceutical component, which must are only used under medical checking. Use of these products could offer the serious risk of health, particularly for patient with existing medical condition such as, warmhearted problems, that, which take the warmhearted medication, or that, which can be in risk.

Zimaxx, Actra-Rx, 4Everon, Vigor-25 And Nasutra advanced for processing erectile dysfunctions. These products - or is possible sold on internet or are brought on Canada road for personal use. However, these products not resolved for selling on Canada.

Zimaxx Adulterated sildenafil, which - an active pharmaceutical component came to light in medicine of the prescription Viagra. Actra-Rx, 4Everon And Nasutra adulterated to modify the forms sildenafil. Vigor-25 adulterated to modify the form vardenafil, which - an active pharmaceutical component came to light in medicine of the prescription Levitra.

Use Zimaxx, Actra-Rx, 4Everon, Vigor-25 and Nasutra could cause serious lateral-effects including sudden loss of the vision, raised warmhearted factor, reduced blood pressure, penile damage fabrics, constant loss of power, and urinary infections of the tract. Other more serious lateral-effects can include the indigestion, headaches, paint and dizziness.

Use of these products can also produce the specific type of the loss of the vision named nonarteritic previous ischemic optical neuropathy on folk by age 50 years, and in with factor of the risk such as, high blood pressure, high cholesterol, diabetes, smoking, or that with blood problem ship in eye, which can conduct to blow. This condition can be irreversible.

The Products, containing sildenafil or vardenafil must is not used individual, who take any nitrate a medication since uniting these products could end the development to potentially lifes-threats of the low blood pressure.

Warning the Canada preceding Health was released for Nasutra during May 2006 since it appears that this product will contain sildenafil. Nasutra Has with be discovered to contain to modify the form sildenafil and be consequently enclosed in this consulting.

The Consumers, which use any five products must cease to send him and address with professional of health if they have an enxiety about its health. The Consumers are informed to address to Product of Health and Food Branch Inspectorate in 1-800-267-9675 if they find any products on Canada. Canada Health have notified the Canadian Border Agency of the Services to delay any cargo of these products on border.

To date, no disadvantage reactions suspected, which it is necessary to get in touch with use these five products are not reported on Canada Health. To report the suspicious disadvantage reaction on this or any other product of health, please address to Canadian Disadvantage Reaction Medicine, checking Program (CADRMP) of the Canada of Health of one of the following methods.